|
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
RECRUITINGSponsored by Supernus Pharmaceuticals, Inc.
Actively Recruiting
SponsorSupernus Pharmaceuticals, Inc.
Started2025-03-31
Est. completion2027-08-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations5 sites
View on ClinicalTrials.gov →
NCT07219927
Summary
Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: Participant has received a prescription for ONAPGO™ according to the standard of care. Participant has opted into receiving support services from the Clinical Nurse Navigator (CNN), a registered nurse specially trained to work with persons with Parkinson's disease, as noted on the Prescription Enrollment Form. The HCP/Investigator determines the participant is an appropriate study participant. Participant is able and willing to provide informed consent (or informed assent form \[IAF\], as applicable) and signs the consent form on the Enrollment Day. Exclusion Criteria: Did not receive a prescription for ONAPGO™. Prescribed ONAPGO™, but the HCP/Investigator determines the participant should not participate in this observational study. Concomitant use of ONAPGO™ with 5-HT3 antagonists, including antiemetics (e.g., ondansetron, granisetron, dolasetron, palonosetron) or alosetron. Known hypersensitivity to apomorphine or to excipients of ONAPGO™, including sulfite (e.g., sodium metabisulfite).
Conditions2
Parkinson DiseaseParkinson's Disease
Locations5 sites
California
3 sitesParkinson's Disease and Movement Disorders Center - Orange County (South)
Aliso Viejo, California, 92656
Mindy Bixby, D.O.
Parkinson's Disease and Movement Disorders Center - Orange County (North)
Irvine, California, 92618
Sandeep Thakkar, D.O.
Parkinson's Research Centers of America - Palo Alto
Palo Alto, California, 94301
Salima Brillman, MD
Florida
1 siteParkinson's Disease & Movement Disorders Center of Boca Raton
Boca Raton, Florida, 33486
Stuart Isaacson, MD
New York
1 siteParkinson's Disease and Movement Disorders Center - Long Island
Commack, New York, 11725
David Kreitzman, M.D.
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorSupernus Pharmaceuticals, Inc.
Started2025-03-31
Est. completion2027-08-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations5 sites
View on ClinicalTrials.gov →
NCT07219927